The first ‘Trends in Cell-Based Assays’ forum was held this week in Cambridge, hosted by ATCC and BioAgilytix, who partnered with Shire Pharmaceuticals, Takeda Pharmaceuticals, Visterra and the former senior advisor of Science Innovation and Policy for the FDA.
Click for full article
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Platforms
Services